Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 8,116 shares at $485.49 ($3.9M) on 2025-03-04, disclosed to the SEC on 2025-03-06.
Scheduled sale ($3.9M) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $485.49 | 4,058 | $2.0M | 50.0% |
| 2 | $485.49 | 4,058 | $2.0M | 50.0% |
| Total | $485.49 avg | 8,116 | $3.9M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |